UHND.com - Notre Dame Football, Basketball, & Recruiting

research, where a lot of new drugs and startups come from...

...here's an AI summary in answer to the question...Do all drugs on the market come from big pharmaceutical companies?

----------------------
AI Overview
No, not all drugs on the market are developed by "big pharma" companies, though they do play a significant role. While large pharmaceutical companies often handle the later stages of drug development, including manufacturing and marketing, a substantial amount of drug discovery originates in universities and smaller biotech companies. Additionally, public funding, particularly through institutions like the National Institutes of Health (NIH), plays a crucial role in foundational research that underpins many drug discoveries.
Here's a more detailed breakdown:
"Big Pharma" is a Misnomer:
While the term "Big Pharma" is often used, it's more accurate to think of it as a complex ecosystem involving various players.
Early-Stage Research:
Much of the foundational research that leads to new drugs originates in universities and academic centers.
Biotech Companies:
Small biotech companies often focus on specific areas of drug discovery and development, sometimes partnering with or being acquired by larger pharmaceutical companies.
Public Funding:
The NIH and other public institutions invest heavily in basic research that forms the basis for many new drugs.
Later-Stage Development:
Large pharmaceutical companies are typically involved in the later stages of drug development, including clinical trials, manufacturing, and marketing.
Collaboration:
Collaboration between universities, biotech companies, and large pharmaceutical companies is increasingly common, with each entity contributing its unique expertise.
Global Production:
While the US plays a significant role in drug development, global manufacturing is more geographically dispersed, with countries like India and China playing a large role in the production of active pharmaceutical ingredients (APIs) and finished drug products.
-------------------

The existing system can work quite when we have strong government oversight that is non-political...as well as government funding for Universities and BioTech startups, so that we're not totally dependent on Big Pharma. DJT seems to be 'Stacking the Deck' in favor of Big Pharma with all his cuts to Oversight and University/BioTech startups. Guess that's what his Plutocrat friends like Peter Theil would like to see.